Brain cancer vaccine - Advanced Biotherapies
Alternative Names: Antisense TGF-beta-2 gene therapyLatest Information Update: 01 Jun 2006
At a glance
- Originator Advanced Biotherapies
- Class Antisense DNA; Cancer vaccines; DNA vaccines; Tumour cell vaccines
- Mechanism of Action Immunostimulants; Transforming growth factor beta replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Glioblastoma